SEC Form 4 · accession 0001235802-17-000032
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Miclot
Director
Period of report
Mar 6, 2017
Accepted (ET)
Mar 7, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2 | Mar 6, 2017 | M | 20,618 | $21.86 | A | 56,496 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F2 | Mar 6, 2017 | S | 20,618 | $28.4961 | D | 35,878 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $21.86 | Mar 6, 2017 | M | 20,618 | D | — | Mar 30, 2017 | Ordinary Shares | 20,618 | 0 | D |
Explanation of responses
- F1The reporting person exercised this option since it was in the money and scheduled to expire on March 30, 2017.
- F2Includes 4,094 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.40 to $28.59, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4This option fully vested on March 30, 2011.